Abstract:IMPORTANCE Individuals genetically predisposed to pancreatic cancer may benefit from early detection. Genes that predispose to pancreatic cancer and the risks of pancreatic cancer associated with mutations in these genes are not well defined. OBJECTIVE To determine whether inherited germline mutations in cancer predisposition genes are associated with increased risks of pancreatic cancer. DESIGN, SETTING, AND PARTICIPANTS Case-control analysis to identify pancreatic cancer predisposition genes; longitudinal analysis of patients with pancreatic cancer for prognosis. The study included 3030 adults diagnosed as having pancreatic cancer and enrolled in aMayo Clinic registry between October 12, 2000, and March 31, 2016, with last follow-up on June 22, 2017. Reference controls were 123 136 individuals with exome sequence data in the public Genome Aggregation Database and 53 105 in the Exome Aggregation Consortium database. EXPOSURES Individuals were classified based on carrying a deleterious mutation in cancer predisposition genes and having a personal or family history of cancer. MAIN OUTCOMES AND MEASURES Germline mutations in coding regions of 21 cancer predisposition genes were identified by sequencing of products from a custom multiplex polymerase chain reaction-based panel; associations of genes with pancreatic cancer were assessed by comparing frequency of mutations in genes of pancreatic cancer patients with those of reference controls. RESULTS Comparing 3030 case patients with pancreatic cancer (43.2% female; 95.6% non-Hispanic white; mean age at diagnosis, 65.3 [SD, 10.7] years) with reference controls, significant associations were observed between pancreatic cancer and mutations in CDKN2A (0.3% of cases and 0.02% of controls; odds ratio [OR], 12.33; 95% CI, 5.43-25.61); TP53 (0.2% of cases and 0.02% of controls; OR, 6.70; 95% CI, 2.52-14.95); MLH1 (0.13% of cases and 0.02% of controls; OR, 6.66; 95% CI, 1.94-17.53); BRCA2 (1.9% of cases and 0.3% of controls; OR, 6.20; 95% CI, 4.62-8.17); ATM (2.3% of cases and 0.37% of controls; OR, 5.71; 95% CI, 4.38-7.33); and BRCA1 (0.6% of cases and 0.2% of controls; OR, 2.58; 95% CI, 1.54-4.05). CONCLUSIONS AND RELEVANCE In this case-control study, mutations in 6 genes associated with pancreatic cancer were found in 5.5% of all pancreatic cancer patients, including 7.9% of patients with a family history of pancreatic cancer and 5.2% of patients without a family history of pancreatic cancer. Further research is needed for replication in other populations.

SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort

Impact of NOTCH1 Polymorphisms on Liver Cancer in a Chinese Han Population

SPINK1, PRSS1, CTRC, and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis.

Comprehensive Screening for PRSS1, SPINK1, CFTR, CTRC and CLDN2 Gene Mutations in Chinese Paediatric Patients with Idiopathic Chronic Pancreatitis: a Cohort Study.

Heterozygous Spink1 c.194+2T>C mutation promotes chronic pancreatitis after acute attack in mice

Genetic Factors Associated with Adverse Pregnancy Outcomes in Chronic Pancreatitis

Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes

An Evaluation Study of Reported Pancreatic Adenocarcinoma Risk-Associated SNPs from Genome-Wide Association Studies in Chinese Population

Machine learning and experiments identifies SPINK1 as a candidate diagnostic and prognostic biomarker for hepatocellular carcinoma

Two Novel PRKCI Polymorphisms and Prostate Cancer Risk in an Eastern Chinese Han Population

SPINK5 is a Tumor-Suppressor Gene Involved in the Progression of Nonsmall Cell Lung Carcinoma through Negatively Regulating PSIP1

SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics

Circulating Proteins and Risk of Pancreatic Cancer: a Case-Subcohort Study among Chinese Adults.

Single-nucleotide polymorphisms based genetic risk score in the prediction of pancreatic cancer risk

Exome-wide Analysis Identifies Three Low-Frequency Missense Variants Associated with Pancreatic Cancer Risk in Chinese Populations

High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT

Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic Analysis and a Predictive Model

Potentially functional variants of CHMP4A and PANX1 in the pyroptosis‐related pathway predict survival of patients with non‐oropharyngeal head and neck squamous cell carcinoma

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer

Identification of Common Variants in BRCA2 and MAP2K4 for Susceptibility to Sporadic Pancreatic Cancer.

Genetic Variations In A Pten/Akt/Mtor Axis And Prostate Cancer Risk In A Chinese Population